TaperRx is healthcare’s first roadmap to tapering patients off
multiple prescription drugs in multiple drug classifications

August 18, 2014 06:01 AM Eastern Daylight Time

ORLANDO, Fla.--(BUSINESS WIRE)--PRIUM, a medical intervention company specializing in reducing the
inappropriate use of prescription drugs, announced its ground-breaking TaperRx
service at the Workers’ Compensation Institute’s Educational Conference
today.

“TaperRx provides physicians a ‘roadmap’ to assist them in reducing or
eliminating the numerous prescription drugs in multiple classifications
that chronic pain patients typically take,” said PRIUM Senior Vice
President Mark Pew.

These drugs often include opioids, non-steroidal anti-inflammatories,
benzodiazepines, muscle relaxants, and/or anti-depressants. Weaning
patients off a mix of drug classifications is complicated because
different drugs require different tapering protocols. Physicians need to
decide which drugs to taper first, how to reduce their dosage, and what
milestones to meet before moving to the next step.

PRIUM’s white paper, “An Analysis of Drug Therapy Tapering Guidelines”
showed that no clinical guidelines address how to wean patients from
multiple drugs in multiple classifications. The white paper is available
at http://www.prium.com/resources/thought-leadership.
TaperRx was developed to help provide clinical clarity to that process.

Using the best available science, PRIUM’s pharmacological and medical
experts developed and oversee TaperRx, which delivers a detailed
tapering roadmap customized to the patient’s unique drug regimen,
physiological and psychosocial circumstances. TaperRx suggests a
personalized tapering strategy with step-by-step recommendations,
providing a clinical rationale for each.

“This is the healthcare industry’s first service to aggregate the best
tapering evidence available to affect change in a complex drug regimen,”
Pew said. “TaperRx augments the physician’s expertise, enables
accountability and facilitates communication among the physician,
patient and payer throughout the weaning process.”

About PRIUM

An Ameritox solutions provider, PRIUM sets the industry standard for
workers’ compensation medical interventions through its ability to
secure higher agreement rates and to help ensure compliance with
modified treatment plans. The hallmark of the medical intervention
company’s success is a collaborative physician engagement process
encompassing evidence-based medicine, clinical oversight, and
jurisdictional guidelines to facilitate optimal financial and clinical
outcomes. PRIUM helps eliminate unnecessary treatment through a
comprehensive approach that includes complex medical interventions,
utilization reviews, urine drug monitoring, and independent medical
exams. Based in Duluth, Ga., PRIUM can be reached at prium.com or
888.588.4964.